<?xml version="1.0" encoding="UTF-8"?>
<p>The EC is the competent authority for centrally authorized products (CAPs), while NCAs are the competent authorities for nationally authorized products (NAPs). The EU regulatory model foresees that while NCAs retain responsibility for medicinal products authorized on their territory, the EMA provides coordination to support the scientific evaluation, supervision, and safety monitoring of all medicines on the EU market.
 <xref rid="pds5133-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref>
</p>
